Fate Therapeutics (FATE) Return on Sales (2016 - 2025)
Fate Therapeutics' Return on Sales history spans 14 years, with the latest figure at 23.74% for Q4 2025.
- For Q4 2025, Return on Sales rose 737.0% year-over-year to 23.74%; the TTM value through Dec 2025 reached 20.56%, down 640.0%, while the annual FY2025 figure was 20.56%, 640.0% down from the prior year.
- Return on Sales reached 23.74% in Q4 2025 per FATE's latest filing, down from 18.47% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.42% in Q1 2023 to a low of 62.36% in Q2 2023.
- Average Return on Sales over 5 years is 15.21%, with a median of 10.77% recorded in 2024.
- Peak YoY movement for Return on Sales: plummeted -5792bps in 2023, then surged 5642bps in 2024.
- A 5-year view of Return on Sales shows it stood at 4.05% in 2021, then surged by 66bps to 1.39% in 2022, then plummeted by -1778bps to 26.05% in 2023, then decreased by -19bps to 31.12% in 2024, then increased by 24bps to 23.74% in 2025.
- Per Business Quant, the three most recent readings for FATE's Return on Sales are 23.74% (Q4 2025), 18.47% (Q3 2025), and 17.85% (Q2 2025).